118
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Impact of cyclodextrin derivatives on systemic release of duloxetine HCl via buccal route

, , , &
Pages 931-945 | Received 09 Jul 2019, Accepted 26 Apr 2020, Published online: 18 May 2020

References

  • Hasler G. Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry. 2010;9(3):155–161.
  • Karpa KD, Cavanaugh JE, Lakoski JM. Duloxetine pharmacology: profile of a dual monoamine modulator. CNS Drug Rev. 2006;8(4):361–376.
  • Wernicke JF, Gahimer J, Yalcin I, et al. Safety and adverse event profile of duloxetine. Expert Opin Drug Saf. 2005;4(6):987–993.
  • FDA US. Environmental assessment finding of no significant impact NDA 22-516. Center for Drug Evaluation and Research; Indianapolis; 2009.
  • Roy S, Pal K, Anis A, et al. Polymers in mucoadhesive drug-delivery systems: a brief note. Des Monomers Polym. 2009;12(6):483–495.
  • Shityakov S, Puskás I, Pápai K, et al. Sevoflurane–sulfobutylether–β-cyclodextrin complex: preparation, characterization, cellular toxicity, molecular modeling and blood-brain barrier transport studies. Molecules. 2015;20(6):10264–10279.
  • Tötterman AM, Schipper NG, Thompson DO, et al. Intestinal safety of water‐soluble β‐cyclodextrins in paediatric oral solutions of spironolactone: effects on human intestinal epithelial Caco‐2 cells. J Pharm Pharmacol. 1997;49(1):43–48.
  • Irie T, Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci. 1997;86(2):147–162.
  • Rathbone MJ, Drummond BK, Tucker IG. The oral cavity as a site for systemic drug delivery. Adv Drug Deliv Rev. 1994;13(1–2):1–22.
  • Meng-Lund E, Jacobsen J, Müllertz A, et al. Buccal absorption of diazepam is improved when administered in bioadhesive tablets—an in vivo study in conscious Gottingen mini-pigs. Int J Pharm. 2016;515(1–2):125–131.
  • Lesch CA, Squier CA, Cruchley A, et al. The permeability of human oral mucosa and skin to water. J Dent Res. 1989;68(9):1345–1349.
  • Longer MA, Robinson JR. Fundamental aspects of bioadhesion. Pharm Int. 1986;7:114–117.
  • Tiwari D, Sause R, Madan PL, et al. Evaluation of polyoxyethylene homopolymers for buccal bioadhesive drug delivery device formulations. AAPS PharmSci. 1999;1(3):50–58.
  • Cantor AS, Wirtanen DJ. Novel acrylate adhesives for transdermal drug delivery. Pharm Technol. 2002;26(1):28–38.
  • Turcotte JE, Debonnel G, de Montigny C, et al. Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects. Neuropsychopharmacol. 2001;24(5):511–521.
  • Vincent S, Bieck PR, Garland EM, et al. Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles. Circulation. 2004;109(25):3202–3207.
  • Kim Y-I, Pradhan R, Paudel BK, et al. Preparation and evaluation of enteric-coated delayed-release pellets of duloxetine hydrochloride using a fluidized bed coater. Arch Pharm Res. 2015;38(12):2163–2171.
  • Alam MI, Baboota S, Ahuja A, et al. Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain. J Psychiatr Res. 2012;46(9):1133–1138.
  • Singh A, Bali A. Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride. J Anal Sci Technol. 2016;7(1):1–13.
  • Varshosaz J, Dehghan Z. Development and characterization of buccoadhesive nifedipine tablets. Eur J Pharm Biopharm. 2002;54(2):135–141.
  • Jug M, Kosalec I, Maestrelli F, et al. Development of low methoxy amidated pectin-based mucoadhesive patches for buccal delivery of triclosan: effect of cyclodextrin complexation. Carbohydr Polym. 2012;90(4):1794–1803.
  • Kumar R, Sarwal A, Dahiya L, et al. Experimental investigations, cytotoxicity and cellular uptake outcomes of physically modified duloxetine HCl inclusion complexes. Polym Bull. 2019;76(11):5865–5887.
  • Mangolim CS, Moriwaki C, Nogueira AC, et al. Curcumin–β-cyclodextrin inclusion complex: stability, solubility, characterisation by FT-IR, FT-Raman, X-ray diffraction and photoacoustic spectroscopy, and food application. Food Chem. 2014;153:361–370.
  • Rodrigues LNC, Issa MG, Asbahr ACC, et al. Multicomponent complex formation between pyrimethamine, cyclodextrins and water-soluble polymers. Braz Arch Biol Technol. 2011;54(5):965–972.
  • Cappello B, De Rosa G, Giannini L, et al. Cyclodextrin-containing poly (ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery system. Int J Pharm. 2006;319(1–2):63–70.
  • Mura P, Cirri M, Mennini N, et al. Polymeric mucoadhesive tablets for topical or systemic buccal delivery of clonazepam: effect of cyclodextrin complexation. Carbohydr Polym. 2016;152:755–763.
  • Kassem MAA, ElMeshad AN, Fares AR. Enhanced bioavailability of buspirone hydrochloride via cup and corebuccal tablets: formulation and in vitro/in vivo evaluation. Int J Pharm. 2014;463(1):68–80.
  • Koradia H, Chaudhari K. Formulation of unidirectional buccal tablet of Mirtazapine: an in vitro and ex vivo evaluation. J Drug Deliv Sci Technol. 2018;43:233–242.
  • Shanker G, Kumar CK, Gonugunta CSR, et al. Formulation and evaluation of bioadhesive buccal drug delivery of tizanidine hydrochloride tablets. AAPS PharmSciTech. 2009;10(2):530–539.
  • El Sharawy AM, Shukr MH, Elshafeey AH. Formulation and optimization of duloxetine hydrochloride buccal films: in vitro and in vivo evaluation. Drug Deliv. 2017;24(1):1762–1769.
  • Bottenberg P, Cleymaet R, Muynck C, et al. Development and testing of bioadhesive, fluoride‐containing slow‐release tablets for oral use. J Pharm Pharmacol. 1991;43(7):457–464.
  • Esim O, Savaser A, Ozkan C, et al. Effect of polymer type on characteristics of buccal tablets using factorial design. Saudi Pharm J. 2018;26(1):53–63.
  • Shidhaye SS, Thakkar PV, Dand NM, et al. Buccal drug delivery of pravastatin sodium. AAPS PharmSciTech. 2010;11(1):416–424.
  • Chen TC, Yu S-C, Hsu C-M, et al. A water-based topical Chinese traditional medicine (Zicao) for wound healing developed using 2-hydroxypropyl-β-cyclodextrin. Colloid Surf B. 2018;165:67–73.
  • Semcheddine F, Guissi NEI, Liu X, et al. Effects of the preparation method on the formation of true nimodipine SBE-β-CD/HP-β-CD inclusion complexes and their dissolution rates enhancement. AAPS PharmSciTech. 2015;16(3):704–715.
  • De Chasteigner S, Fessi H, Devissaguet JP, et al. Comparative study of the association of itraconazole with colloidal drug carriers. Drug Dev Res. 1996;38(2):125–133.
  • Kurkov SV, Loftsson T. Cyclodextrins. Int J Pharm. 2013;453(1):167–180.
  • Jansook P, Kurkov SV, Loftsson T. Cyclodextrins as solubilizers: formation of complex aggregates. J Pharm Sci. 2010;99(2):719–729.
  • Yatsu FK, Koester LS, Lula I, et al. Multiple complexation of cyclodextrin with soy isoflavones present in an enriched fraction. Carbohydr Polym. 2013;98(1):726–735.
  • Saokham P, Muankaew C, Jansook P, et al. Solubility of cyclodextrins and drug/cyclodextrin complexes. Molecules. 2018;23(5):1161–1115.
  • Pandya P, Pandey NK, Singh SK, et al. Formulation and characterization of ternary complex of poorly soluble duloxetine hydrochloride. J Appl Pharm Sci. 2015;5:88–96.
  • Kulkarni AD, Belgamwar VS. Inclusion complex of chrysin with sulfobutyl ether-β-cyclodextrin (Captisol®): preparation, characterization, molecular modelling and in vitro anticancer activity. J Mol Struct. 2017;1128:563–571.
  • Xu C, Tang Y, Hu W, et al. Investigation of inclusion complex of honokiol with sulfobutyl ether-β-cyclodextrin. Carbohydr Polym. 2014;113:9–15.
  • Ol'khovich MV, Sharapova AV, Perlovich GL, et al. Inclusion complex of antiasthmatic compound with 2-hydroxypropyl-β-cyclodextrin: preparation and physicochemical properties. J Mol Liq. 2017;237:185–192.
  • Hixson A, Crowell J. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem. 1931;23(8):923–931.
  • Çelik B. Risperidone mucoadhesive buccal tablets: formulation design, optimization and evaluation. Drug Des Devel Ther. 2017;11:3355–3365.
  • Abdelkader H, Abdalla OY, Salem H. Formulation of controlled-release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation. AAPS PharmSciTech. 2007;8(4):E100.
  • Singh SK, Vuddanda PR, Singh S, et al. A comparison between use of spray and freeze drying techniques for preparation of solid self-microemulsifying formulation of valsartan and in vitro and in vivo evaluation. Biomed Res Int. 2013;2013:1–13.
  • Tóth G, Jánoska Á, Völgyi G, et al. Physicochemical characterization and cyclodextrin complexation of the anticancer drug lapatinib. J Chem. 2017;2017:1–9.
  • Szente L, Szejtli J. Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Adv Drug Deliv Rev. 1999;36(1):17–28.
  • Zhu Z, Zhai Y, Zhang N, et al. The development of polycarbophil as a bioadhesive material in pharmacy. Asian J Pharm Sci. 2013;8(4):218–227.
  • Betageri GV, Deshmukh DV, Gupta RB. Oral sustained-release bioadhesive tablet formulation of didanosine. Drug Dev Ind Pharm. 2001;27(2):129–136.
  • Park S-H, Chun M-K, Choi H-K. Preparation of an extended-release matrix tablet using chitosan/carbopol interpolymer complex. Int J Pharm. 2008;347(1–2):39–44.
  • Patel VM, Prajapati BG, Patel MM. Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride. AAPS PharmSciTech. 2007;8(1):E147–E154.
  • Onishi H, Yumoto K, Sakata O. Preparation and evaluation of ritodrine buccal tablets for rational therapeutic use. Int J Pharm. 2014;468(1–2):207–213.
  • Peppas NA, Sahlin JJ. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm. 1989;57(2):169–172.
  • Ritger PL, Peppas NA. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5(1):37–42.
  • Pendekal MS, Tegginamat PK. Development and characterization of chitosan-polycarbophil interpolyelectrolyte complex-based 5-fluorouracil formulations for buccal, vaginal and rectal application. Daru. 2012;20(1):1–11.
  • Şenel S, Hıncal AA. Drug permeation enhancement via buccal route: possibilities and limitations. J Control Release. 2001;72(1–3):133–144.
  • Panda B, Subhadarsini R, Mallick S. Biointerfacial phenomena of amlodipine buccomucosal tablets of HPMC matrix system containing polyacrylate polymer/β-cyclodextrin: correlation of swelling and drug delivery performance. Expert Opin Drug Deliv. 2016;13(5):633–643.
  • Hornof MD, Bernkop-Schnürch A. In vitro evaluation of the permeation enhancing effect of polycarbophil–cysteine conjugates on the cornea of rabbits. J Pharm Sci. 2002;91(12):2588–2592.
  • Cody S, Xiang S, Layton M, et al. A simple method allowing DIC imaging in conjunction with confocal microscopy. J Microsc. 2005;217(3):265–274.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.